Literature DB >> 12062887

Information processing characteristics in subtypes of multiple sclerosis.

L M J De Sonneville1, J B Boringa, I E W Reuling, R H C Lazeron, H J Adèr, C H Polman.   

Abstract

The purpose of this study was to evaluate information processing characteristics in patients with multiple sclerosis (MS). We selected 53 patients with MS and 58 matched healthy controls. Using computerized tests, we investigated focused, divided, sustained attention, and executive function, and attempted to pinpoint deficits in attentional control to peripheral or central processing stages. The results substantiate the hypothesis that the slowing of attention-demanding (controlled) information processing underlying more complex cognitive skills is general, i.e. irrespective of type of controlled processing, with MS patients being 40% slower than controls. MS patients may suffer from focused, and divided and sustained attention deficits, as well as from compromised central processing stages, with secondary progressive (SP) patients showing the most extensive range of deficits, closely followed by primary progressive (PP) patients, while relapsing-remitting (RR) patients appear to be much less affected. General slowing appears to be highest in PP and SP type MS patients (50% slower) versus relapsing-remitting MS (24% slower). In contrast to most previous results, (complex) processing speed appeared to be robustly correlated with severity of MS as measured by the expanded disability status scale and with disease duration. Patients did much less differ in accuracy of processing from controls, suggesting the importance of using time strategies in planning everyday life and job activities to compensate for or alleviate MS-related speed handicaps. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12062887     DOI: 10.1016/s0028-3932(02)00041-6

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  20 in total

1.  Discriminant analysis of the cognitive performance profile of MS patients differentiates their clinical course.

Authors:  Jürgen A Kraus; Cathleen Schütze; Barbara Brokate; Beate Kröger; Günther Schwendemann; Helmut Hildebrandt
Journal:  J Neurol       Date:  2005-03-06       Impact factor: 4.849

2.  Are motor inhibition and cognitive flexibility dead ends in ADHD?

Authors:  Nanda N J Rommelse; Marieke E Altink; Leo M J de Sonneville; Cathelijne J M Buschgens; Jan Buitelaar; Jaap Oosterlaan; Joseph A Sergeant
Journal:  J Abnorm Child Psychol       Date:  2007-05-15

3.  Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.

Authors:  Suzanne L Barker-Collo; Suzanne C Purdy
Journal:  Int J MS Care       Date:  2013

4.  Cognition in the early stage of multiple sclerosis.

Authors:  Doreen Schulz; Bruno Kopp; Annett Kunkel; Jürgen H Faiss
Journal:  J Neurol       Date:  2006-04-11       Impact factor: 4.849

5.  Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.

Authors:  M R Piras; I Magnano; E D G Canu; K S Paulus; W M Satta; A Soddu; M Conti; A Achene; G Solinas; I Aiello
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

6.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

Review 7.  Cognitive impairment in multiple sclerosis.

Authors:  Alexander Winkelmann; Claudia Engel; Annett Apel; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

8.  High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Amber E ten Hoedt; Leo M J de Sonneville; Baudouin Francois; Nienke M ter Horst; Mirian C H Janssen; M Estela Rubio-Gozalbo; Frits A Wijburg; Carla E M Hollak; Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2010-12-10       Impact factor: 4.982

9.  Long-term effects of cranial irradiation and intrathecal chemotherapy in treatment of childhood leukemia: a MEG study of power spectrum and correlated cognitive dysfunction.

Authors:  Marita Daams; Ilse Schuitema; Bob W van Dijk; Eline van Dulmen-den Broeder; Anjo Jp Veerman; Cor van den Bos; Leo Mj de Sonneville
Journal:  BMC Neurol       Date:  2012-08-28       Impact factor: 2.474

10.  What is the relevance of quality of life assessment for patients with attention impairment?

Authors:  Karine Baumstarck; Mohamed Boucekine; Irina Klemina; Françoise Reuter; Valérie Aghababian; Anderson Loundou; Jean Pelletier; Pascal Auquier
Journal:  Health Qual Life Outcomes       Date:  2013-04-25       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.